State health officials are taking the pharmaceutical company at its word that a 100-million dose goal will be met by the summer. But racial gaps persist in the effort to vaccinate more Black and Brown residents. The needle hasn’t moved much, with just 15% of all administered doses having gone to Hispanic or Black individuals. Dr. Robert L. Johnson, dean of Rutgers New Jersey Medical School and interim dean of its Robert Wood Johnson Medical School, discusses the issue. Read the Full Article.
Home / Community / Dr. Johnson featured on NJ Spotlight news: Why is vaccine equity still lagging among NJ’s Black and brown residents?
Recent Posts
- Founding partner Microsoft to bring new Discovery AI technology to NJ AI Hub.
- In Once-Redlined City Neighborhoods, Ambulances Still Lag Behind.
- How Alcohol Ads in Your Feed May Lead to Alcohol in Your Glass.
- Launch of NJIT’s B.S. in Enterprise AI Cultivates Next-Generation Tech Talent.
- Landmark Data from Rutgers Cancer Institute and RWJBarnabas Health Show Long-term Complete Responses of T Cell Therapies for HPV-Related Cancers.
Categories
- Community (2,401)
- Covid (993)
- CTO Events (6)
- News (3,039)
- Pilots (21)